|
NUP54 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.737700E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.476000E-03 |
| Normal-vs-Stage2 |
2.458600E-01 |
| Normal-vs-Stage3 |
1.309820E-01 |
| Normal-vs-Stage4 |
5.753000E-01 |
| Stage1-vs-Stage2 |
3.963200E-01 |
| Stage1-vs-Stage3 |
6.900200E-01 |
| Stage1-vs-Stage4 |
4.156200E-01 |
| Stage2-vs-Stage3 |
6.973800E-01 |
| Stage2-vs-Stage4 |
8.633200E-01 |
| Stage3-vs-Stage4 |
6.512200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.959200E-03 |
| Normal-vs-AfricanAmerican |
6.429700E-02 |
| Normal-vs-Asian |
3.174600E-01 |
| Caucasian-vs-AfricanAmerican |
6.980200E-01 |
| Caucasian-vs-Asian |
8.129800E-01 |
| AfricanAmerican-vs-Asian |
9.232800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.555100E-03 |
| Normal-vs-Female |
2.918200E-01 |
| Male-vs-Female |
4.490000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.238200E-02 |
| Normal-vs-Extreme_Weight |
2.903400E-03 |
| Normal-vs-Obese |
3.879900E-02 |
| Normal-vs-Extreme_Obese |
2.168300E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.235400E-01 |
| Normal_Weight-vs-Obese |
7.778200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.403600E-01 |
| Extreme_Weight-vs-Obese |
3.534600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.211000E-01 |
| Obese-vs-Extreme_Obese |
4.510000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.249200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.276200E-02 |
| Normal-vs-Age(61-80Yrs) |
1.223890E-03 |
| Normal-vs-Age(81-100Yrs) |
5.638000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.088600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.041580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.488300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.412300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.532450E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.690600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.554420E-02 |
| Normal-VS-Type2 PRCC |
6.37510000000008E-05 |
| Normal-VS-KIRP CIMP |
9.104600E-01 |
| Normal-VS-Unclassified PRCC |
2.415800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.744600E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.200400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.322400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.663900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.057800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.833600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.1208999999911E-05 |
| Normal-vs-N1 |
8.581000E-01 |
| Normal-vs-N2 |
1.244360E-02 |
| N0-vs-N1 |
1.458040E-02 |
| N0-vs-N2 |
6.026000E-01 |
| N1-vs-N2 |
1.788020E-01 |
|
|
